Medios
Medios (Frankfurt Stock Exchange/Prime Standard/ISIN: DE000A1MMCC8) is the leading provider of specialty pharmaceuticals and the production of patient-specific therapies focusing on smallest batches and concomitantly growing into advanced therapies. The Company supports key partners in the supply chain with innovative solutions and intelligent services. Medios has focused on pioneering individualized medicine in order to make the most innovative therapies available to everyone together with pharmacies, specialist medical practices and pharmaceutical companies.
